Avantor (NYSE:AVTR) Cut to Buy at Wall Street Zen

Avantor (NYSE:AVTR – Get Free Report) was downgraded by investment analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Sunday, Wall Street Zen reports.

AVTR has been the topic of a number of other reports. Morgan Stanley lifted their price objective on Avantor from $14.00 to $15.00 and gave the stock an “equal weight” rating in a research note on Tuesday, October 13th. UBS Group assumed coverage on Avantor in a research note on Wednesday, September 9th. They set a “neutral” rating and a $16.00 target price for the company. Evercore set a $17.00 target price on Avantor in a report on Wednesday, October 28th. Deutsche Bank reaffirmed a “hold” rating and issued a $17.00 target price on shares of Avantor in a report on Thursday, October 29th. Finally, Jefferies Financial Group raised Avantor from an “underperform” rating to a “hold” rating and set a $13.00 price target on the stock in a research report on Wednesday, July 29th. Two research analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $14.77.

Read Our Latest Stock Report on AVTR

Avantor Price Performance

Shares of AVTR stock opened at $14.82 on Friday. The firm has a market cap of $10.04 billion, a P/E ratio of 29.64, a P/E/G ratio of 6.72 and a beta of 0.95. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.89 and a quick ratio of 1.27. The firm has a fifty day moving average of $15.72 and a two-hundred day moving average of $11.52. Avantor has a 1-year low of $7.26 and a 1-year high of $17.45.

Avantor (NYSE:AVTR – Get Free Report) last announced its quarterly earnings results on Wednesday, October 28th. The company reported $0.22 EPS for the quarter, beating the consensus estimate of $0.21 by $0.01. Avantor had a return on equity of 9.79% and a net margin of 5.08%. The company had revenue of $1.70 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter last year, the company posted $0.22 earnings per share. The company’s revenue for the quarter was up 4.6% compared to the same quarter last year. As a group, research analysts anticipate that Avantor will post 0.81 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in AVTR. GSA Capital Partners LLP acquired a new position in Avantor in the second quarter valued at approximately $800,000. Oppenheimer Asset Management Inc. bought a new position in Avantor in the second quarter valued at approximately $805,000. Assenagon Asset Management S.A. boosted its stake in Avantor by 425.0% in the second quarter. Assenagon Asset Management S.A. now owns 556,871 shares of the company’s stock valued at $5,513,000 after acquiring an additional 450,801 shares during the last quarter. Freestone Grove Partners LP acquired a new stake in Avantor during the 2nd quarter worth $56,577,000. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new stake in Avantor during the 2nd quarter worth $1,922,000. Institutional investors own 95.08% of the company’s stock.

Top Avantor Stories

These are some of the AVTR stories that stood out recently:

  • Positive Sentiment: Zacks raised its FY2026 EPS estimate to $0.81 from $0.80, FY2027 to $0.86 from $0.85, and FY2028 to $0.93 from $0.92. It also lifted estimates for Q1–Q3 2027 and Q2 2028, suggesting slightly better expectations across much of the forecast period. Avantor analyst estimates
  • Negative Sentiment: Zacks lowered its Q4 2026 EPS estimate to $0.21 from $0.22 and Q4 2027 to $0.21 from $0.23, indicating some weaker expectations for those quarters. Avantor analyst estimates
  • Neutral Sentiment: Overall, the changes are small and partly offsetting; Zacks’ FY2026 forecast of $0.81 is close to the cited analyst consensus of $0.82. The reports provide no major new company-specific catalyst to explain a decisive move in AVTR shares. Avantor analyst estimates

About Avantor

(Get Free Report)

Avantor, Inc. is a global provider of products and services used in life sciences, advanced technology and applied materials. Its customers include biopharmaceutical and healthcare companies, laboratories, universities and manufacturers. The company supplies chemicals, reagents, laboratory consumables and equipment, as well as materials used in biopharmaceutical production. Avantor also provides services such as procurement, inventory management and support for laboratory and production operations.

Featured Articles

Analyst Recommendations for Avantor (NYSE:AVTR)

Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.